JP2015510770A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510770A5
JP2015510770A5 JP2015500714A JP2015500714A JP2015510770A5 JP 2015510770 A5 JP2015510770 A5 JP 2015510770A5 JP 2015500714 A JP2015500714 A JP 2015500714A JP 2015500714 A JP2015500714 A JP 2015500714A JP 2015510770 A5 JP2015510770 A5 JP 2015510770A5
Authority
JP
Japan
Prior art keywords
peptide
vsdl
cleavage site
fusion polypeptide
terminus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015500714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510770A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/000273 external-priority patent/WO2013138850A1/en
Publication of JP2015510770A publication Critical patent/JP2015510770A/ja
Publication of JP2015510770A5 publication Critical patent/JP2015510770A5/ja
Pending legal-status Critical Current

Links

JP2015500714A 2012-03-19 2013-03-19 組換えペプチドの産生方法 Pending JP2015510770A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261612817P 2012-03-19 2012-03-19
US61/612,817 2012-03-19
PCT/AU2013/000273 WO2013138850A1 (en) 2012-03-19 2013-03-19 Method of producing a recombinant peptide

Publications (2)

Publication Number Publication Date
JP2015510770A JP2015510770A (ja) 2015-04-13
JP2015510770A5 true JP2015510770A5 (enExample) 2016-05-19

Family

ID=49221695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015500714A Pending JP2015510770A (ja) 2012-03-19 2013-03-19 組換えペプチドの産生方法

Country Status (8)

Country Link
US (1) US20150315259A1 (enExample)
EP (1) EP2839010B1 (enExample)
JP (1) JP2015510770A (enExample)
KR (1) KR20140148420A (enExample)
CN (2) CN107266554A (enExample)
AU (2) AU2013234860B2 (enExample)
SG (1) SG11201405721VA (enExample)
WO (1) WO2013138850A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8947194B2 (en) 2009-05-26 2015-02-03 Solaredge Technologies Ltd. Theft detection and prevention in a power generation system
EP3773669A4 (en) * 2018-03-29 2022-04-27 Contrafect Corporation ANTIMICROBIAL BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE BACTERIA
CN113121637B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种重组蛋白的分离纯化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691310A (en) 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides
GB9716790D0 (en) * 1997-08-07 1997-10-15 Creative Peptides Sweden Ab Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
ES2263278T3 (es) * 1998-07-10 2006-12-01 Scios Inc. Metodo para producir un peptido con un pl por encima de 8 o por debajo de 5.
WO2000017336A1 (en) * 1998-09-19 2000-03-30 Sang Jun Lee Dna cassette encoding a multimer of a biologically active peptide and a cleavable linker attached thereto and process for preparing the biologically active peptide
US6759510B1 (en) * 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
CN1363654A (zh) * 2001-07-19 2002-08-14 上海华谊生物技术有限公司 生产促胰岛素分泌肽glp-1(7-36)的基因工程菌以及生产glp-1(7-36)的方法
ES2343061T3 (es) * 2002-05-24 2010-07-22 Medtronic, Inc. Metodos y constructos de dna para produccion de polipeptidos con rendimiento alto.
DE60331584D1 (de) * 2002-11-26 2010-04-15 Biocon Ltd Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen
WO2005094420A2 (en) * 2004-02-17 2005-10-13 University Of South Florida Materials and methods for treatment of inflammatory and cell proliferation disorders
EP1736480B9 (en) * 2005-06-02 2009-03-04 Polyquant GmbH Artificial protein, method for absolute quantification of proteins and uses thereof
JP5395794B2 (ja) * 2007-09-11 2014-01-22 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのガラニンペプチドの使用
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
US8527211B2 (en) * 2008-06-18 2013-09-03 Reza Zareie Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization
JP2013505013A (ja) * 2009-09-18 2013-02-14 セレクシス エス.エー. 強化導入遺伝子発現およびプロセッシングの産物および方法
WO2012019237A1 (en) * 2010-08-12 2012-02-16 Madeleine Pharmaceuticals Pty Ltd Therapeutic method for treating congestive heart failure
WO2012115772A2 (en) * 2011-02-25 2012-08-30 Medtronic, Inc. Therapy for kidney disease and/or heart failure

Similar Documents

Publication Publication Date Title
HRP20200871T1 (hr) Izmjenjeni rsv f proteini i postupci njihove uporabe
JP2005120106A5 (enExample)
JP2025028857A5 (enExample)
FI4176894T3 (fi) Kimeerisiä tekijä viii -proteiineja ja niiden käyttötarkoituksia
JP2018537087A5 (enExample)
JP2004532033A5 (enExample)
AR108442A1 (es) Proteínas de fusión gdf15 y usos de estas
RU2017123283A (ru) Партнеры по слиянию для получения пептидов
JP2015504052A5 (enExample)
JP2017500035A5 (enExample)
JP2009268467A5 (enExample)
JP2015524403A5 (enExample)
JP2011501971A5 (enExample)
NZ597685A (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
JP2017506886A5 (enExample)
JP2015212284A5 (enExample)
JPWO2020072821A5 (enExample)
JP2020529221A5 (enExample)
JP2010530903A5 (enExample)
CA2636075A1 (en) Chimaeric fusion protein with superior chaperone and folding activities
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
JP2014504297A5 (enExample)
EP2589658A4 (en) PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN
JP2015510770A5 (enExample)
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras